3rd Quarter - Report — BIOGEN for BIOGEN (2012)

Firm

BIOGEN

Client

BIOGEN

Income

—

Expenses

$415,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Lobbyist	Covered position, as disclosed
ADAM GLUCK	Staff, Senate HELP Committee
KATHLEEN TREGONING	Staff, House Ways and Means Committee

Contacted: Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans-Pacific Partnership (TPP) trade agreement.

Lobbyist	Covered position, as disclosed
ADAM GLUCK	Staff, Senate HELP Committee
KATHLEEN TREGONING	Staff, House Ways and Means Committee

Contacted: HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); SENATE; U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

Support domestic and international corporate tax policies which protect and incentivize US-based research and manufacturing jobs.

Lobbyist	Covered position, as disclosed
ADAM GLUCK	Staff, Senate HELP Committee
KATHLEEN TREGONING	Staff, House Ways and Means Committee

Contacted: U.S. Trade Representative (USTR); Natl Economic Council (NEC); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

1) Opposition to proposals to weaken incentives included in the biosimilars law for innovation and second generation therapies.

Lobbyist	Covered position, as disclosed
ADAM GLUCK	Staff, Senate HELP Committe
KATHLEEN TREGONING	Staff, House Ways and Means Committee

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Natl Economic Council (NEC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.